肥胖杂志

肥胖杂志/2020年/文章/选项卡3

研究文章

体重变化及其与代谢疾病风险标记在超重和肥胖的妇女

表3

意味着改变代谢疾病风险因素按重量改变类别在减肥干预阶段。

代谢疾病风险标记 6个月减肥干预阶段(基线)
控制 干预
> 2%的涨幅 ±2%的维护 > 2 - < 5%的损失 5 - 20%的损失 价值 > 2%的涨幅 ±2%的维护 > 2 - < 5%的损失 5 - 20%的损失 - - - - - -价值
n= 18 n= 48 n= 29 n= 19 n= 15 n= 57 n= 45 n= 12

WC,厘米 −1.27 −1.88 −3.51 −7.63美国广播公司 < 0.001 −0.77 −2.14 −4.24 −5.67一个 0.002
(−3.70,1.16) (−3.35−0.41) (−5.39−1.62) (−9.96−5.29) (−2.86,1.31) (−3.20−1.08) (−5.44−3.04) (−7.98−3.36)
台塑,更易与L −0.37 0.09 −0.05 −0.12 0.434 −0.03 0.07 −0.35 −0.19 0.065
(−0.85,0.10) (−0.20,0.38) (−0.42,0.33) (−0.59,0.34) (−0.08,0.38) (−0.48,0.27) (−0.33,0.16) (−0.67,0.03)
空腹胰岛素,μU /毫升 0.79 0.37 −0.38 −1.32 0.346 −1.08 0.99 −0.36 −4.27一个 0.022
(−0.34,0.77) (−0.79,1.52) (−1.86,1.10) (−3.19,0.54) (−3.91,1.74) (−0.43,2.41) (−1.95,1.24) (−7.35−1.19)
HOMA-IR 0.22 0.17 −0.17 −0.45 0.218 −0.55 0.07 −0.48 −0.63 0.190
(−0.66,1.84) (−0.19,0.53) (−0.63,0.29) (−1.02,0.12) (−1.34,0.24) (−0.33,0.46) (−0.92−0.03) (−1.48,0.23)
甘油三酸酯,更易与L 0.02 −0.01 0.28 0.11 0.253 0.14 0.18 0.07 −0.25 0.166
(−0.28,0.31) (−0.19,0.17) (0.05,0.51) (−0.18,0.40) (−0.17,0.45) (0.02,0.34) (−0.11,0.25) (−0.60,0.10)
TC,更易与L −0.10 −0.32 −0.26 −0.32 0.760 −0.31 −0.30 0.03 −0.59 0.022
(−0.45,0.24) (−0.53−0.11) (−0.53,0.01) (−0.65,0.02) (−0.67,0.06) (−0.48−0.11) (−0.18,0.24) (−0.99−0.19)
高密度脂蛋白胆固醇,更易与L −0.04 −0.04 −0.09 −0.05 0.674 −0.04 0.01 −0.01 −0.01 0.880
(−0.13,0.06) −0.10,0.02) (−0.17−0.02) (−0.14,0.04) (−0.15,0.07) (−0.05,0.07) (−0.08,0.05) (−0.13,0.12)
低密度,更易与L −0.35 −0.02 −0.07 −0.37 0.412 −0.23 −0.11 0.06 0.08 0.563
(−0.79,0.10) (−0.29,0.26) (−0.42,0.28) (−0.81,0.06) (−0.65,0.20) (−0.33,0.10) (−0.19,0.30) (−0.39,0.55)
肿瘤坏死因子-αpg / mL 2.76 4.52 4.50 3.66 0.613 0.23 2.43 4.15 5.65 0.182
(0.44,5.09) (3.04,6.00) (2.62,6.37) (1.35,5.98) (−3.78,4.25) (0.45,4.42) (2.04,6.26) (1.80,9.49)
脂联素,μ克/毫升 0.89 −2.11 −1.81 5.46ab < 0.001 1.94 1.86 −0.30 −1.75 0.403
(−1.87,3.64) (−3.93−0.28) (−3.91,0.28) (2.48,8.43) (−2.58,6.47) (−0.22,3.94) (−2.61,2.01) (−5.81,2.32)
Hs-CRP, mg / L 1.92 0.62 0.74 0.58 0.779 0.83 −1.15 −1.57 0.60 0.110
(−0.33,4.16) (−0.79,2.03) (−0.99,2.47) (−1.49,2.65) (−1.37,3.03) (−2.21−0.09) (−2.72−0.43) (−1.48,2.68)

请注意。数据作为估计边际的意思(95% CI)。一个显著差异相对于> 2%体重增加。b显著差异相对于±2%重量维护。c显著差异,相对于减肥> 2 - < 5%。 参与者的数量的胰岛素、HOMA-IR和炎症标记物如下:胰岛素。反对:> 2%:18±2%维护:44岁> 2 - < 5%的损失:27岁,5 - 20%的损失:17。INT > 2%: 14±2%维护:54岁> 2 - < 5%的损失:43和5 - 20%损失:12。HOMA-IR。反对:> 2%:18±2%维护:42岁> 2 - < 5%的损失:26日和5 - 20%损失:17。INT > 2%: 14±2%维护:54岁> 2 - < 5%的损失:43和5 - 20%损失:12。炎症标记物。反对:> 2%:11日±2%维护:27日> 2 - < 5%的损失:18 - 5 - 20%的损失:13。INT > 2%: 10,±2%维护:34岁> 2 - < 5%的损失:29日和5 - 20%的损失:9。

文章奖:2020年杰出的研究贡献,选择由我们的首席编辑。获奖的文章阅读